A review of adjuvant hormonal therapy in breast cancer

Endocrine-related Cancer
Kellie L Jones, A Buzdar

Abstract

Breast cancer is the most common carcinoma diagnosed in women today excluding non-melanoma skin cancers. It has been well documented that estrogen plays a critical role in its development and is a major target for treatment. For many years, tamoxifen has been the gold standard for adjuvant hormonal therapy in breast cancer patients. With newer products targeting different mechanisms to suppress estrogen production, patients now have many decisions regarding their care. Agents such as luteinizing hormone releasing hormone (LHRH) agonists can suppress ovarian function in premenopausal patients and have been shown to be as effective and even better than chemotherapy (CMF--cyclophosphamide, methotrexate, fluorouracil-containing regimens) in certain patient populations. Tamoxifen continues to be an option as well as toremifene, a similar selective estrogen receptor modulator. With the advent of newer third generation aromatase inhibitors (anastrozole, letrozole and exemestane) toxicities have been documented to be less and in some cases they are more efficacious than the standard, tamoxifen. This article reviews the current data regarding ovarian suppression, ovarian suppression plus tamoxifen, tamoxifen, toremifene, anastrozole, le...Continue Reading

Citations

Sep 1, 2012·Molecules and Cells·Suhwan Chang, Shyam K Sharan
Dec 2, 2005·Breast Cancer Research and Treatment·Dimitrios T P TrafalisCharalambos Camoutsis
Feb 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Paul C BoutrosIgor Jurisica
Jan 25, 2007·World Journal of Surgical Oncology·Myrna CandelariaAlfonso Duenas-Gonzalez
Dec 20, 2011·Endocrine-related Cancer·Gavin P VinsonJohn R Puddefoot
Apr 25, 2007·Current Eye Research·Solange Rios SalomãoMarcia Motono
Jan 24, 2006·Climacteric : the Journal of the International Menopause Society·P GuptaI Paterson
Jul 18, 2008·Supportive Cancer Therapy·Aarati RanganathanDebu Tripathy
Oct 3, 2012·Journal of Pain and Symptom Management·Kristin HofsøChristine Miaskowski
Jul 22, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Maida WongAntonio La Cava
Apr 16, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·S SantoroG De Panfilis
Jan 24, 2006·Pharmacology & Therapeutics·Tarek Hakki, Rita Bernhardt
Aug 6, 2005·Journal of Molecular Biology·Christopher D FlemingMatthew R Redinbo
May 17, 2011·Chemico-biological Interactions·Carla Brugin MarekAdelar Bracht
Aug 24, 2016·Cancer Causes & Control : CCC·Leslie V FarlandStacey A Missmer
Feb 18, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lesley J FallowfieldEmma Hall
May 2, 2016·European Journal of Medicinal Chemistry·Changhao WangHerman O Sintim
Mar 29, 2016·World Journal of Methodology·Crystal C LipseyRuben R Gonzalez-Perez
Sep 28, 2005·Angewandte Chemie·Bathula S Reddy, Rajkumar Banerjee
Sep 16, 2011·Expert Review of Anticancer Therapy·Federica TomaoSilverio Tomao
Nov 18, 2006·The Oncologist·Edith A Perez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.